Harbor Capital Advisors’s Bio-Techne TECH Stock Holding History

Harbor Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-49,272	Closed	-$2.89M	–	1426
2025 Q1	$2.89M	Buy	+49,272	New	+$3.34M	0.13%	226

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Harbor Capital Advisors's TECH Position: Q2 2025 in Review

Harbor Capital Advisors sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 49,272 shares — an estimated $2.89M sold.

Harbor Capital Advisors first reported a position in TECH in Q1 2025 and held it in 1 quarter. The position peaked at $2.89M in Q1 2025. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Harbor Capital Advisors reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Harbor Capital Advisors sold 49,272 Bio-Techne shares in Q2 2025, an estimated $2.89M.
Harbor Capital Advisors first reported a position in Bio-Techne in Q1 2025 and held it in 1 quarter.
Harbor Capital Advisors's Bio-Techne position peaked at $2.89M in Q1 2025.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Harbor Capital Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.